SUMMARY BACKGROUND: Recurrent gram-negative bloodstream infection (BSI) has not been evaluated in a population-based setting; therefore, we performed a population-based retrospective cohort study to examine the incidence, recurrence, and mortality rates of gram-negative BSI. METHODS: We identified 944 episodes of gram-negative BSI, including 98 recurrent episodes, among Olmsted County, Minnesota, residents from 1/1/1998 to 12/31/2007. Kaplan-Meier method was used to estimate the cumulative incidence rate of recurrence and 28-day all-cause mortality rate of gram-negative BSI. Cox proportional hazard regression was used to determine risk factors for recurrence. RESULTS: The overall age- and gender-adjusted incidence rate of gram-negative BSI per 100,000 person-years was 84.5 (95% confidence interval [CI]: 79.1-90.0), including 75.7 (95% CI: 70.6-80.8) for first episodes and 8.8 (95% CI: 7.1-10.6) for recurrent episodes. Among 846 patients with first episodes of gram-negative BSI, the cumulative incidence rates of recurrence after 1, 5, and 10 years of the initial episode were 5.6%, 9.2%, and 14.6%, respectively, with death treated as a competing risk. Patients with Klebsiella species were more likely than those with Escherichia coli BSI to develop recurrent gram-negative BSI (hazard ratio: 2.33 [95% CI: 1.34-3.92], p=0.003). The 28-day all-cause mortality rates following the initial and second episodes of gram-negative BSI were 10.0% (95% CI: 8.0-12.0) and 11.3% (95% CI: 4.4-18.2), respectively. CONCLUSIONS: Even though recurrent gram-negative BSI was relatively uncommon in the general population, up to 15% of patients with gram-negative BSI developed a recurrent episode within 10 years of the initial episode. Copyright (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
SUMMARY BACKGROUND: Recurrent gram-negative bloodstream infection (BSI) has not been evaluated in a population-based setting; therefore, we performed a population-based retrospective cohort study to examine the incidence, recurrence, and mortality rates of gram-negative BSI. METHODS: We identified 944 episodes of gram-negative BSI, including 98 recurrent episodes, among Olmsted County, Minnesota, residents from 1/1/1998 to 12/31/2007. Kaplan-Meier method was used to estimate the cumulative incidence rate of recurrence and 28-day all-cause mortality rate of gram-negative BSI. Cox proportional hazard regression was used to determine risk factors for recurrence. RESULTS: The overall age- and gender-adjusted incidence rate of gram-negative BSI per 100,000 person-years was 84.5 (95% confidence interval [CI]: 79.1-90.0), including 75.7 (95% CI: 70.6-80.8) for first episodes and 8.8 (95% CI: 7.1-10.6) for recurrent episodes. Among 846 patients with first episodes of gram-negative BSI, the cumulative incidence rates of recurrence after 1, 5, and 10 years of the initial episode were 5.6%, 9.2%, and 14.6%, respectively, with death treated as a competing risk. Patients with Klebsiella species were more likely than those with Escherichia coli BSI to develop recurrent gram-negative BSI (hazard ratio: 2.33 [95% CI: 1.34-3.92], p=0.003). The 28-day all-cause mortality rates following the initial and second episodes of gram-negative BSI were 10.0% (95% CI: 8.0-12.0) and 11.3% (95% CI: 4.4-18.2), respectively. CONCLUSIONS: Even though recurrent gram-negative BSI was relatively uncommon in the general population, up to 15% of patients with gram-negative BSI developed a recurrent episode within 10 years of the initial episode. Copyright (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
Authors: Imad M Tleyjeh; James M Steckelberg; Hani S Murad; Nandan S Anavekar; Hassan M K Ghomrawi; Zaur Mirzoyev; Sherif E Moustafa; Tanya L Hoskin; Jayawant N Mandrekar; Walter R Wilson; Larry M Baddour Journal: JAMA Date: 2005-06-22 Impact factor: 56.272
Authors: Daniel Z Uslan; Sarah J Crane; James M Steckelberg; Franklin R Cockerill; Jennifer L St Sauver; Walter R Wilson; Larry M Baddour Journal: Arch Intern Med Date: 2007-04-23
Authors: Majdi N Al-Hasan; John W Wilson; Brian D Lahr; Kristine M Thomsen; Jeanette E Eckel-Passow; Emily A Vetter; Imad M Tleyjeh; Larry M Baddour Journal: Antimicrob Agents Chemother Date: 2009-01-21 Impact factor: 5.191
Authors: Avery N Nelson; Julie Ann Justo; P Brandon Bookstaver; Joseph Kohn; Helmut Albrecht; Majdi N Al-Hasan Journal: Infection Date: 2017-05-06 Impact factor: 3.553
Authors: Joshua T Thaden; Yanhong Li; Felicia Ruffin; Stacey A Maskarinec; Jonathan M Hill-Rorie; Lisa C Wanda; Shelby D Reed; Vance G Fowler Journal: Antimicrob Agents Chemother Date: 2017-02-23 Impact factor: 5.191